ARCHIVES

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase

December 19, 1997

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010

Next Bypass Budget: Slim, Trim, Modest

September 15, 1995

In Brief: Susan Braun Named CEO, Komen Foundation; NCCF Research Fellowship Honors Norman

July 12, 1996

Clinton Administration Issues Research Misconduct Policy.

December 8, 2000

O’Leary Leads RPCI’s OR;

February 8, 2002